Use of Ultrasound to give pain relief will be tested in patients who are morbidly obese and are undergoing surgery

Recruiting

• Conditions: Morbidly Obese patients undergoing Bariatric Surgery

• Registration Number: CTRI/2011/12/002267
• Lead Sponsor: Max Super Speciality Hospital

Brief Summary

**Aims and Objectivesxml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /**

General anaesthesia in morbidly obese is associated with risk of multiple cardiopulmonary complications. These can be further aggravated with sedation, immobilization and hypoventilation from administration of narcotic analgesics in the postoperative period . We wished to study the analgesic potential of TAP block which produces dermatosensory block of the lower six thoracic and upper lumbar abdominal afferents , in this vulnerable group of patients .We believe this group of patients would benefit from opioid sparing effect of this block. In our literature search we did not come across any study which has evaluated the possible benefits of this block in this patient population.

**Hypothesis**

We hypothesised that use of ultrasound guided TAP (USG TAP) block as a part of multimodal analgesia will minimise postoperative opioid requirement, expedite ambulation and minimise adverse events in morbidly obese patients undergoing laparoscopic gastric bypass under general anaesthesia.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-03-08
• Last Update Posted: 2011-12-17

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

BMI> 35 Kg/m2 Either Gender Posted for Laparoscopic bariatric surgery Under general anaesthesia.

Exclusion Criteria

1.Any relevant drug allergy 2.Seizure disorder 3.Antidepressants.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Requirement of Tramazac hydrochloride in first 24 hours after surgery	Requirement of Tramazac hydrochloride in first 24 hours after surgery

Secondary Outcome Measures

Name	Time	Method
: VAS score, RASS ((Richmond Agitation - Sedation Scale; table 1), time to ambulate, adverse events	First 24 hours from end of surgery

Trial Locations

Locations (1)

Max Institute of Minimal Access, Metabolic and Bariatric Surgery; 🇮🇳 Delhi, DELHI, India

Max Institute of Minimal Access, Metabolic and Bariatric Surgery

🇮🇳Delhi, DELHI, India

Aparna Sinha

Principal investigator

09810035503

apsin@hotmail.com